Effects of Catechol-O-Methyltransferase Inhibitors and L-3,4-Dihydroxyphenylalanine With or Without Carbidopa on Extracellular Dopamine in Rat Striatum
- 1 January 1993
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 60 (1) , 137-144
- https://doi.org/10.1111/j.1471-4159.1993.tb05831.x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis studyBrain Research, 1992
- Behavioural and neurochemical effects of Ro 40-7592, a new COMT inhibitor with a potential therapeutic activity in Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1990
- Striatal L-dopa metabolism studied in vivo in rats with nigrostriatal lesionsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1990
- Neural mechanisms of dystonia: Evidence from a 2‐deoxyglucose uptake study in a primate model of dopamine agonist‐induced dystoniaMovement Disorders, 1990
- Catechol‐O‐methyltransferase‐Inhibiting Pyrocatechol Derivatives: Synthesis and Structure‐Activity StudiesHelvetica Chimica Acta, 1989
- Intracerebral dialysis monitoring of striatal dopamine release and metabolism in response to L-DOPAJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- Synthesis of some novel potent and selective catechol O-methyltransferase inhibitorsJournal of Medicinal Chemistry, 1989
- The Pharmacology of Levodopa in Treatment of Parkinson’s Disease: An UpdatePublished by Springer Nature ,1989
- The mechanisms of action of L-dopa in Parkinson's diseaseLife Sciences, 1974
- The metabolism of L‐3–0‐methyldopa, aprecursor of dopa in manClinical Pharmacology & Therapeutics, 1971